Go Pro

Algorhythm (RIME) Competitors

Algorhythm logo
$0.24 +0.00 (+2.03%)
Closing price 09/11/2026 04:00 PM Eastern
Extended Trading
$0.25 +0.01 (+3.03%)
As of 09/11/2026 07:27 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

RIME vs. JF, SMSI, AIXC, ADVB, and HPAI

Should you buy Algorhythm stock or one of its competitors? Algorhythm's main competitors and comparable companies include J And Friends (JF), Smith Micro Software (SMSI), AIxCrypto (AIXC), Advanced Biomed (ADVB), and Helport AI (HPAI). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "application software" industry.

How does Algorhythm compare to J And Friends?

Algorhythm (NASDAQ:RIME) and J And Friends (NASDAQ:JF) are both small-cap technology companies, but which is the superior stock? We will compare the two companies based on the strength of their analyst recommendations, profitability, risk, valuation, institutional ownership, dividends, media sentiment and earnings.

J And Friends has lower revenue, but higher earnings than Algorhythm.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Algorhythm$4.39M0.93-$15.87M-$1.49N/A
J And Friends$1.60M10.99-$1.32MN/AN/A

J And Friends has a net margin of 0.00% compared to Algorhythm's net margin of -176.39%. J And Friends' return on equity of 0.00% beat Algorhythm's return on equity.

Company Net Margins Return on Equity Return on Assets
Algorhythm-176.39% -1,310.33% -101.29%
J And Friends N/A N/A N/A

6.6% of J And Friends shares are owned by institutional investors. 0.9% of Algorhythm shares are owned by insiders. Comparatively, 4.1% of J And Friends shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Algorhythm
1 Sell rating(s)
1 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.50
J And Friends
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.00

In the previous week, Algorhythm and Algorhythm both had 1 articles in the media. J And Friends' average media sentiment score of 1.92 beat Algorhythm's score of 0.93 indicating that J And Friends is being referred to more favorably in the news media.

Company Overall Sentiment
Algorhythm Positive
J And Friends Very Positive

Algorhythm has a beta of -0.25, suggesting that its stock price is 125% less volatile than the broader market. Comparatively, J And Friends has a beta of 1.01, suggesting that its stock price is 1% more volatile than the broader market.

Summary

J And Friends beats Algorhythm on 9 of the 11 factors compared between the two stocks.

How does Algorhythm compare to Smith Micro Software?

Smith Micro Software (NASDAQ:SMSI) and Algorhythm (NASDAQ:RIME) are both small-cap technology companies, but which is the better stock? We will contrast the two businesses based on the strength of their institutional ownership, valuation, media sentiment, analyst recommendations, profitability, risk, dividends and earnings.

Smith Micro Software has a beta of 0.73, meaning that its stock price is 27% less volatile than the broader market. Comparatively, Algorhythm has a beta of -0.25, meaning that its stock price is 125% less volatile than the broader market.

In the previous week, Smith Micro Software had 2 more articles in the media than Algorhythm. MarketBeat recorded 3 mentions for Smith Micro Software and 1 mentions for Algorhythm. Smith Micro Software's average media sentiment score of 1.57 beat Algorhythm's score of 0.93 indicating that Smith Micro Software is being referred to more favorably in the media.

Company Overall Sentiment
Smith Micro Software Very Positive
Algorhythm Positive

Smith Micro Software presently has a consensus price target of $12.50, indicating a potential upside of 331.03%. Given Smith Micro Software's stronger consensus rating and higher probable upside, research analysts clearly believe Smith Micro Software is more favorable than Algorhythm.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Smith Micro Software
1 Sell rating(s)
0 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
2.33
Algorhythm
1 Sell rating(s)
1 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.50

Smith Micro Software has a net margin of -92.60% compared to Algorhythm's net margin of -176.39%. Smith Micro Software's return on equity of -44.59% beat Algorhythm's return on equity.

Company Net Margins Return on Equity Return on Assets
Smith Micro Software-92.60% -44.59% -31.78%
Algorhythm -176.39%-1,310.33%-101.29%

20.8% of Smith Micro Software shares are owned by institutional investors. 34.7% of Smith Micro Software shares are owned by company insiders. Comparatively, 0.9% of Algorhythm shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

Algorhythm has lower revenue, but higher earnings than Smith Micro Software. Smith Micro Software is trading at a lower price-to-earnings ratio than Algorhythm, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Smith Micro Software$17.36M0.93-$29.33M-$3.52N/A
Algorhythm$4.39M0.93-$15.87M-$1.49N/A

Summary

Smith Micro Software beats Algorhythm on 13 of the 16 factors compared between the two stocks.

How does Algorhythm compare to AIxCrypto?

Algorhythm (NASDAQ:RIME) and AIxCrypto (NASDAQ:AIXC) are both small-cap technology companies, but which is the superior investment? We will compare the two businesses based on the strength of their analyst recommendations, institutional ownership, profitability, earnings, dividends, risk, valuation and media sentiment.

AIxCrypto has a net margin of 0.00% compared to Algorhythm's net margin of -176.39%. AIxCrypto's return on equity of -599.14% beat Algorhythm's return on equity.

Company Net Margins Return on Equity Return on Assets
Algorhythm-176.39% -1,310.33% -101.29%
AIxCrypto N/A -599.14%-86.38%

Algorhythm has higher revenue and earnings than AIxCrypto. Algorhythm is trading at a lower price-to-earnings ratio than AIxCrypto, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Algorhythm$4.39M0.93-$15.87M-$1.49N/A
AIxCryptoN/AN/A-$16.97M-$5.68N/A

Algorhythm has a beta of -0.25, meaning that its stock price is 125% less volatile than the broader market. Comparatively, AIxCrypto has a beta of 0.57, meaning that its stock price is 43% less volatile than the broader market.

3.2% of AIxCrypto shares are owned by institutional investors. 0.9% of Algorhythm shares are owned by company insiders. Comparatively, 0.4% of AIxCrypto shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.

In the previous week, AIxCrypto had 4 more articles in the media than Algorhythm. MarketBeat recorded 5 mentions for AIxCrypto and 1 mentions for Algorhythm. Algorhythm's average media sentiment score of 0.93 beat AIxCrypto's score of 0.43 indicating that Algorhythm is being referred to more favorably in the media.

Company Overall Sentiment
Algorhythm Positive
AIxCrypto Neutral

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Algorhythm
1 Sell rating(s)
1 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.50
AIxCrypto
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.00

Summary

AIxCrypto beats Algorhythm on 7 of the 13 factors compared between the two stocks.

How does Algorhythm compare to Advanced Biomed?

Algorhythm (NASDAQ:RIME) and Advanced Biomed (NASDAQ:ADVB) are both small-cap technology companies, but which is the better investment? We will contrast the two companies based on the strength of their dividends, institutional ownership, analyst recommendations, valuation, media sentiment, profitability, earnings and risk.

Advanced Biomed has lower revenue, but higher earnings than Algorhythm. Algorhythm is trading at a lower price-to-earnings ratio than Advanced Biomed, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Algorhythm$4.39M0.93-$15.87M-$1.49N/A
Advanced BiomedN/AN/A-$3.26M$4.821.70

Advanced Biomed has a net margin of 0.00% compared to Algorhythm's net margin of -176.39%. Advanced Biomed's return on equity of 87.74% beat Algorhythm's return on equity.

Company Net Margins Return on Equity Return on Assets
Algorhythm-176.39% -1,310.33% -101.29%
Advanced Biomed N/A 87.74%64.49%

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Algorhythm
1 Sell rating(s)
1 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.50
Advanced Biomed
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.00

Algorhythm has a beta of -0.25, indicating that its stock price is 125% less volatile than the broader market. Comparatively, Advanced Biomed has a beta of -0.29, indicating that its stock price is 129% less volatile than the broader market.

In the previous week, Advanced Biomed had 1 more articles in the media than Algorhythm. MarketBeat recorded 2 mentions for Advanced Biomed and 1 mentions for Algorhythm. Advanced Biomed's average media sentiment score of 1.45 beat Algorhythm's score of 0.93 indicating that Advanced Biomed is being referred to more favorably in the news media.

Company Overall Sentiment
Algorhythm Positive
Advanced Biomed Positive

Summary

Advanced Biomed beats Algorhythm on 8 of the 11 factors compared between the two stocks.

How does Algorhythm compare to Helport AI?

Helport AI (NASDAQ:HPAI) and Algorhythm (NASDAQ:RIME) are both small-cap technology companies, but which is the better business? We will compare the two businesses based on the strength of their risk, analyst recommendations, earnings, media sentiment, dividends, profitability, institutional ownership and valuation.

Helport AI has a net margin of 0.00% compared to Algorhythm's net margin of -176.39%. Helport AI's return on equity of 0.00% beat Algorhythm's return on equity.

Company Net Margins Return on Equity Return on Assets
Helport AIN/A N/A N/A
Algorhythm -176.39%-1,310.33%-101.29%

Helport AI has higher revenue and earnings than Algorhythm.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Helport AI$34.86M0.32$1.86MN/AN/A
Algorhythm$4.39M0.93-$15.87M-$1.49N/A

62.4% of Helport AI shares are held by institutional investors. 13.3% of Helport AI shares are held by company insiders. Comparatively, 0.9% of Algorhythm shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

In the previous week, Helport AI had 1 more articles in the media than Algorhythm. MarketBeat recorded 2 mentions for Helport AI and 1 mentions for Algorhythm. Helport AI's average media sentiment score of 1.31 beat Algorhythm's score of 0.93 indicating that Helport AI is being referred to more favorably in the media.

Company Overall Sentiment
Helport AI Positive
Algorhythm Positive

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Helport AI
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.00
Algorhythm
1 Sell rating(s)
1 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.50

Helport AI has a beta of -0.07, meaning that its share price is 107% less volatile than the broader market. Comparatively, Algorhythm has a beta of -0.25, meaning that its share price is 125% less volatile than the broader market.

Summary

Helport AI beats Algorhythm on 10 of the 12 factors compared between the two stocks.

Get Algorhythm News Delivered to You Automatically

Sign up to receive the latest news and ratings for RIME and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding RIME and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

RIME vs. The Competition

MetricAlgorhythmSoftware IndustryTechnology SectorNASDAQ Exchange
Market Cap$4.09M$15.48B$30.15B$12.85B
Dividend YieldN/A3.44%2.74%11.71%
P/E Ratio-0.16123.7668.6220.85
Price / Sales0.931,292.15592.5590.72
Price / CashN/A41.7446.5934.96
Price / Book-0.458.297.736.21
Net Income-$15.87M$434.47M$704.35M$358.54M
7 Day Performance11.95%-2.04%-1.08%-2.35%
1 Month Performance-46.81%-2.34%-4.27%-3.23%
1 Year Performance-88.48%-0.28%180.50%8.79%

Algorhythm Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
RIME
Algorhythm
0.92 of 5 stars
$0.24
+2.0%
N/A-88.5%$4.09M$4.39MN/A27
JF
J And Friends
0.5108 of 5 stars
$0.94
+2.2%
N/AN/A$17.22M$1.60MN/A78
SMSI
Smith Micro Software
3.0157 of 5 stars
$2.88
+1.4%
$12.50
+334.0%
-16.9%$16.10M$16.88MN/A370
AIXC
AIxCrypto
0.4234 of 5 stars
$0.79
+1.3%
N/AN/A$15.99MN/AN/A50
ADVB
Advanced Biomed
1.3478 of 5 stars
$9.62
-7.9%
N/AN/A$15.88MN/A1.9940

Related Companies and Tools


This page (NASDAQ:RIME) was last updated on 9/13/2026 by MarketBeat.com Staff.
From Our Partners